Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Third pivotal trial for lisofylline

Feb. 26, 1997

New approach to brain cancer introduced

Feb. 26, 1997

U.S. researchers reveal agents for reversing MDR

Feb. 25, 1997

Oxford GlycoSciences describes pyrimidine-based glycoconjugates

Feb. 25, 1997

SCRAS discloses novel topoisomerase inhibitors

Feb. 25, 1997

NIH seeks licensees for cancer vaccines

Feb. 24, 1997

CD40 ligands and MAbs offered for licensing

Feb. 24, 1997

National Patent/PolyMASC extend cancer vaccine collaboration

Feb. 21, 1997

PFT inhibitors described by Warner-Lambert

Feb. 20, 1997

Antitumor heterocyclic compounds from Takeda

Feb. 20, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Recombinant vaccine inhibits HBV-associated HCC growth
BioWorld Science
Chronic liver disease and hepatocellular carcinoma (HCC) associated with chronic hepatitis B virus (HBV) are serious health problems in highly endemic areas....